PMA device
Navitor TAVI System with Vision Technology
Abbott Medical · Aortic Valve, Prosthesis, Percutaneously Delivered (NPT, Class III) · First FDA decision Jun 3, 2026, newest Jun 3, 2026Aortic stenosis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
10
Naming "Navitor TAVI"
MAUDE reports
18
Brand "Navitor TAVI", since 2015
PubMed studies
0
Mentioning "Navitor TAVI"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Navitor TAVI System with Vision Technology
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Navitor TAVI System with Vision TechnologyPMA supplement
P190023-S029 · Decided Jun 3, 2026 · 180 days after receipt · Normal 180 Day Track No User Fee
Device type: Aortic valve, prosthesis, percutaneously delivered (NPT) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Transcatheter Aortic Valve Replacement (TAVR)National analysisReview closedCAG-00430RUpdated Sep 23, 2026
- Transcatheter Aortic Valve Replacement (TAVR)National analysisReview closedCAG-00430NUpdated Sep 23, 2026
- Transcatheter Aortic Valve Replacement (TAVR) for Aortic Regurgitation (AR)National analysisUnder reviewCAG-00430R3Updated Sep 14, 2026
- Transcatheter Aortic Valve Replacement (TAVR)National analysisReview closedCAG-00430R2Updated Sep 10, 2026
- Transcatheter Aortic Valve Replacement (TAVR)National determinationOn the books20.32Updated Aug 16, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Navitor TAVI", any status and sponsor, newest update first.
- Portico Next Generation Approval StudyActive, not recruiting
Abbott Medical DevicesPublic (ABT)
NCT04011722 · 333 participants · Start Sep 17, 2019 · Primary completion Jan 12, 2023
Device: Portico™ NG (Navitor) Valve and FlexNav™ Delivery System; Navitor Titan Valve (35mm) Valve and Large FlexNav™ Delivery System · For: Symptomatic Severe Aortic Stenosis
Sites: Los Angeles, California; Thousand Oaks, California; Washington D.C., District of Columbia · 28 sites in all
- ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve ImplantationPivotal-lookingEnrolling by invitation
Abbott Medical DevicesPublic (ABT)
NCT05932615 · 1,500 participants (planned) · Start Mar 15, 2024 · Primary completion Apr 2027
Device: Navitor Transcatheter Aortic Valve Implantation (TAVI) System; Any Commercially Available Transcatheter Aortic Valve (CAV) System · For: Aortic Valve Stenosis; Heart Valve Diseases; Aortic Valve Disease and 1 more
Sites: Birmingham, Alabama; Phoenix, Arizona; Tucson, Arizona · 107 sites in all
- Balloon- Versus Self-Expanding Intraannular TAVI in Small Aortic AnnuliPivotal-lookingNot yet recruiting
Universitätsklinikum Hamburg-EppendorfAcademic, hospital or other
NCT07794306 · 510 participants (planned) · Start Oct 26, 2026 · Primary completion Jul 31, 2028
Device: Meril Octapro+ THV System; Abbott Navitor/Navitor Vision THV system · For: Aortic Valve Stenosis
Sites: Hamburg, Germany
7 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Navitor TAVI", and for the whole product code for context.
This brand
18 reports: 0 malfunction, 16 injury, 2 death
Whole product code NPT
77,669 reports: 12,243 malfunction, 57,723 injury, 7,693 death
Newest reports for this brand
3005334138-2022-00176 · Received Mar 14, 2022 · Event dated Feb 11, 2022
Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Device problem as coded: Perivalvular Leak
Patient problem as coded: Low Blood Pressure/ Hypotension; Diminished Pulse Pressure; Aortic Valve Insufficiency/ Regurgitation
3005334138-2022-00203 · Received Mar 8, 2022
Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Device problem as coded: Adverse Event Without Identified Device or Use Problem; Patient Device Interaction Problem
Patient problem as coded: Thrombosis/Thrombus
ST. JUDE MEDICAL, COSTA RICA LTDA
3005334138-2022-00207 · Received Mar 8, 2022 · Event dated Feb 23, 2022
Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Device problem as coded: Migration or Expulsion of Device
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Abbott Navitor Titan, Vision Technology, Transcatheter Aortic Heart Valve, 35 mm, NVRO-35, SterileOpen, Classified
Z-0491-2025 · Started Oct 17, 2024 · Posted by FDA Nov 20, 2024
Reason given: A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the impacted valve and/or cause potential valve failure.
Cause as FDA categorized it: Under Investigation by firm · Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
Z-0492-2025 · Started Oct 17, 2024 · Posted by FDA Nov 20, 2024
Reason given: A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the impacted valve and/or cause potential valve failure.
Cause as FDA categorized it: Under Investigation by firm · Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
- Abbot Navitor, Vision Technology, Transcatheter Aortic Heart Valve, 29 mm, NVRO-29, SterileOpen, Classified
Z-0493-2025 · Started Oct 17, 2024 · Posted by FDA Nov 20, 2024
Reason given: A manufacturing error resulting in acceptance of valves with a leaflet deflection value that was outside of established specifications. This could potentially affect long-term durability of the impacted valve and/or cause potential valve failure.
Cause as FDA categorized it: Under Investigation by firm · Device type: Aortic Valve, Prosthesis, Percutaneously Delivered (NPT)
2 more recall records with a free account
Published research
The most relevant PubMed records for "Navitor TAVI"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code NPT.
- Sapien 3 Transcatheter Heart Valve and AccessoriesEdwards Lifesciences, LLC · PMA 2025
- Medtronic CoreValve Evolut R SystemMedtronic, Inc. · PMA 2022
- Edwards SAPIEN XT Transcatheter Heart ValveEdwards Lifesciences, LLC · PMA 2020
- Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart ValveEdwards Lifesciences, LLC · PMA 2026
- Medtronic CoreValve SystemMedtronic, Inc. · PMA 2023
- Edwards Sapien Transcatheter Heart Valve and Transfemoral and Transapical AccessoriesEdwards Lifesciences, LLC · PMA 2013
- Navitor Transcatheter Aortic Valve Implantation SystemAbbott Medical · PMA 2026
- Trilogy Transcatheter Heart Valve SystemJenaValve Technology, Inc. · PMA 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.